ECS BOTANICS HOLDINGS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.019 AUD | +5.56% |
|
+11.76% | -15.56% |
| May. 17 | ECS Botanics Secures First B2C Medicinal Cannabis Contract | MT |
| Feb. 27 | ECS Botanics Holdings Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 7.18M 4.78M | Sales 2023 | 15.39M 10.25M | Capitalization | 27.67M 18.43M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -666K | Net income 2023 | - 0 | EV / Sales 2022 | 2.36 x |
| Net cash position 2022 | 1.85M 1.23M | Net cash position 2023 | 2.21M 1.47M | EV / Sales 2023 | 1.65 x |
| P/E ratio 2022 |
-15.5
x | P/E ratio 2023 |
-205
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.67% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.56% | ||
| 1 week | +11.76% | ||
| Current month | -9.52% | ||
| 1 month | -9.52% | ||
| 3 months | -20.83% | ||
| 6 months | -17.39% | ||
| Current year | -15.56% |
1 week
0.02
0.02
1 month
0.020.02
Current year
0.020.03
1 year
0.020.03
3 years
0.010.05
5 years
0.010.09
10 years
0.010.09
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 21-03-14 | |
Arthur Sun
DFI | Director of Finance/CFO | - | 21-04-30 |
Angela Macquire
COO | Chief Operating Officer | - | 21-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeremy King
CHM | Chairman | 50 | 17-01-10 |
| Chief Executive Officer | - | 21-03-14 | |
Michael Nitsche
BRD | Director/Board Member | - | 19-03-24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 0.019 | +5.56% | 1 465 321 |
| 24-05-20 | 0.018 | -10.00% | 1,226,962 |
| 24-05-17 | 0.02 | +11.11% | 2,232,885 |
| 24-05-16 | 0.018 | 0.00% | 87,878 |
| 24-05-15 | 0.018 | +5.88% | 3,090,053 |
Delayed Quote Australian S.E., May 21, 2024 at 12:44 am EDT
More quotes
ECS Botanics Holdings Ltd is an Australia-based medicinal cannabis company. The Company is engaged in the cultivation and manufacturing of good manufacturing practice (GMP) medicinal cannabis with a facility in Northwest Victoria. The Company operates through two segments: ECS Botanics Pty Ltd, and Murray Meds Pty Ltd and Flowerday Farms Pty Ltd. ECS Botanics Pty Ltd is engaged in the sale of food and wellness products. Murray Meds Pty Ltd and Flowerday Farms Pty Ltd are engaged in the sale of medicinal cannabis plant-related products. It cultivates a range of strains for extraction and inhalation. The Company extracts resin from its strains for the formulation of oils and other products.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.56% | 15.49M | |
| -.--% | 339M | |
| +52.26% | 299M | |
| +35.05% | 279M | |
| +168.19% | 154M | |
| +45.65% | 132M | |
| -41.95% | 119M | |
| -28.57% | 122M | |
| +34.62% | 118M | |
| +100.00% | 60.26M |
- Stock Market
- Equities
- ECS Stock
